Chemotherapy toxicity and quality of life in older women with advanced or recurrent endometrial cancer: An NRG Oncology - Gynecologic Oncology Group ancillary study

被引：0
|
作者：
Ko, E. M. [1 ]
Java, J. [2 ]
Van Le, L. [3 ]
Schmitz, K. [4 ]
Randall, M. E. [5 ]
Bloss, J. D. [6 ]
Fleming, G. [7 ]
Moore, D. H. [8 ]
Monk, B. J. [9 ]
Muss, H. B. [10 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Gynecol Oncol Grp, Stat & Data Ctr, Buffalo, NY USA
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Univ Kentucky, Med Ctr, Lexington, KY USA
[6] Astella Pharma, Northbrook, IL USA
[7] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[8] Franciscan Phys Network Gynecol Oncol Specialists, Indianapolis, IN USA
[9] Univ Arizona, Ctr Canc, Phoenix, AZ USA
[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
73
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [41] Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
    Walker, Joan L.
    Brady, Mark F.
    Wenzel, Lari
    Fleming, Gini F.
    Huang, Helen Q.
    DiSilvestro, Paul A.
    Fujiwara, Keiichi
    Alberts, David S.
    Zheng, Wenxin
    Tewari, Krishnansu S.
    Cohn, David E.
    Powell, Matthew A.
    Van Le, Linda
    Davidson, Susan A.
    Gray, Heidi J.
    Rose, Peter G.
    Aghajanian, Carol
    Myers, Tashanna
    Secord, Angeles Alvarez
    Rubin, Stephen C.
    Mannel, Robert S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (16) : 1380 - +
  • [42] Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)
    Tewari, Krishnansu S.
    Sill, Michael W.
    Monk, Bradley J.
    Penson, Richard T.
    Moore, David H.
    Lankes, Heather A.
    Ramondetta, Lois M.
    Landrum, Lisa M.
    Randall, Leslie M.
    Oaknin, Ana
    Leitao, Mario M.
    Eisenhauer, Eric L.
    DiSilvestro, Paul
    Van Le, Linda
    Pearl, Michael L.
    Burke, James J.
    Salani, Ritu
    Richardson, Debra L.
    Michael, Helen E.
    Kindelberger, David W.
    Birrer, Michael J.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (11) : 2363 - 2370
  • [43] Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study
    Olawaiye, Alexander B.
    Java, James J.
    Krivak, Thomas C.
    Friedlander, Michael
    Mutch, David G.
    Glaser, Gretchen
    Geller, Melissa
    O'Malley, David M.
    Wenham, Robert M.
    Lee, Roger B.
    Bodurka, Diane C.
    Herzog, Thomas J.
    Bookman, Michael A.
    GYNECOLOGIC ONCOLOGY, 2018, 151 (01) : 18 - 23
  • [44] FINAL OVERALL SURVIVAL ANALYSIS OF THE PHASE III RANDOMIZED TRIAL OF CHEMOTHERAPY WITH AND WITHOUT BEVACIZUMAB FOR ADVANCED CERVICAL CANCER: A NRG ONCOLOGY - GYNECOLOGIC ONCOLOGY GROUP STUDY
    Tewari, K. S.
    Sill, M. W.
    Penson, R. T.
    Huang, H.
    Ramondetta, L. M.
    Landrum, L. M.
    Oaknin, A.
    Reid, T. J.
    Leitao, M. M.
    Monk, B. J.
    Michael, H. E.
    ANNALS OF ONCOLOGY, 2014, 25
  • [45] Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer
    Tewari K.S.
    Monk B.J.
    Current Oncology Reports, 2005, 7 (6) : 419 - 434
  • [46] Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study
    Deborah Watkins Bruner
    Andrea Barsevick
    Chunqiao Tian
    Marcus Randall
    Robert Mannel
    David E. Cohn
    Joel Sorosky
    Nick M. Spirtos
    Quality of Life Research, 2007, 16 : 89 - 100
  • [47] Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study
    Watkins Bruner, Deborah
    Barsevick, Andrea
    Tian, Chunqiao
    Randall, Marcus
    Mannel, Robert
    Cohn, David E.
    Sorosky, Joel
    Spirtos, Nick M.
    QUALITY OF LIFE RESEARCH, 2007, 16 (01) : 89 - 100
  • [48] Receipt of adjuvant endometrial carcinoma treatment according to race: An NRG Oncology/Gynecologic Oncology Group 210 Study.
    Felix, Ashley
    Cohn, David
    Brasky, Theodore
    Mutch, David
    Creasman, William
    Thaker, Premal
    Walker, Joan
    Moore, Richard
    Lele, Shashikant
    Guntupalli, Saketh
    Downs, Levi
    Nagel, Christa
    Boggess, John
    Pearl, Michael
    Ioffe, Olga
    Deng, Wei
    Randall, Marcus
    Brinton, Louise
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 99 - 100
  • [49] A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
    Jandial, Danielle A.
    Brady, William E.
    Howell, Stephen B.
    Lankes, Heather A.
    Schilder, Russell J.
    Beumer, Jan H.
    Christner, Susan M.
    Strychor, Sandra
    Powell, Matthew A.
    Hagemann, Andrea R.
    Moore, Kathleen N.
    Walker, Joan L.
    DiSilvestro, Paul A.
    Duska, Linda R.
    Fracasso, Paula M.
    Dizon, Don S.
    GYNECOLOGIC ONCOLOGY, 2017, 145 (02) : 236 - 242
  • [50] What is the Role of Retroperitoneal Exploration in Optimally Debulked Stage IIIC Epithelial Ovarian Cancer? An NRG Oncology/Gynecologic Oncology Group Ancillary Data Study
    Rungruang, Bunja J.
    Miller, Austin
    Krivak, Thomas C.
    Horowitz, Neil S.
    Rodriguez, Noah
    Hamilton, Chad A.
    Backes, Floor J.
    Carson, Linda F.
    Friedlander, Michael
    Mutch, David G.
    Goodheart, Michael J.
    Tewari, Krishnansu S.
    Wenham, Robert M.
    Bookman, Michael A.
    Maxwell, G. Larry
    Richard, Scott D.
    CANCER, 2017, 123 (06) : 985 - 993
12345